<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18</volume><submitter>Kao YL</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Contralateral recurrence of upper-tract urothelial carcinoma (UTUC) presents a clinical challenge, with limited evidence regarding optimal surgical management.&lt;h4>Objective&lt;/h4>To compare oncological outcomes among patients with contralateral UTUC recurrence managed by second nephroureterectomy (NUR) or nephron-sparing surgery (NSS), relative to those undergoing primary NUR.&lt;h4>Design&lt;/h4>A multicentre retrospective cohort study.&lt;h4>Methods&lt;/h4>In this multicentre retrospective cohort, 3159 patients diagnosed with UTUC between 2018 and 2024 in the Taiwanese UTUC Registry were analysed. Patients undergoing curative-intent surgery were grouped as follows: unilateral UTUC treated with primary NUR; contralateral recurrence treated with a second NUR; and contralateral recurre</pubmed_abstract><journal>Therapeutic advances in urology</journal><pagination>17562872261419593</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12901921</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Contralateral recurrent upper-tract urothelial carcinoma after curative surgery: a multicentre retrospective cohort study.</pubmed_title><pmcid>PMC12901921</pmcid><pubmed_authors>Tsai CY</pubmed_authors><pubmed_authors>Chen IA</pubmed_authors><pubmed_authors>Ou CH</pubmed_authors><pubmed_authors>Wu HC</pubmed_authors><pubmed_authors>Huang CY</pubmed_authors><pubmed_authors>Chang CH</pubmed_authors><pubmed_authors>Wu WJ</pubmed_authors><pubmed_authors>Li CC</pubmed_authors><pubmed_authors>Tsai YC</pubmed_authors><pubmed_authors>Cheng PY</pubmed_authors><pubmed_authors>Kao YL</pubmed_authors><pubmed_authors>Yu CC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Contralateral recurrent upper-tract urothelial carcinoma after curative surgery: a multicentre retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Contralateral recurrence of upper-tract urothelial carcinoma (UTUC) presents a clinical challenge, with limited evidence regarding optimal surgical management.&lt;h4>Objective&lt;/h4>To compare oncological outcomes among patients with contralateral UTUC recurrence managed by second nephroureterectomy (NUR) or nephron-sparing surgery (NSS), relative to those undergoing primary NUR.&lt;h4>Design&lt;/h4>A multicentre retrospective cohort study.&lt;h4>Methods&lt;/h4>In this multicentre retrospective cohort, 3159 patients diagnosed with UTUC between 2018 and 2024 in the Taiwanese UTUC Registry were analysed. Patients undergoing curative-intent surgery were grouped as follows: unilateral UTUC treated with primary NUR; contralateral recurrence treated with a second NUR; and contralateral recurre</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan-Dec</publication><modification>2026-07-15T22:02:38.969Z</modification><creation>2026-07-09T13:09:37.333Z</creation></dates><accession>S-EPMC12901921</accession><cross_references><pubmed>41694265</pubmed><doi>10.1177/17562872261419593</doi></cross_references></HashMap>